Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc

Bullboard Posts

Post by Hiddensecretson Jul 27, 2020 3:02pm

142 Views

Post# 31326068

HLTH expecting revenue of: $ 286,000,000

In addition, Global Care will pay CDN$5,000,000 payable in cash on hand or common shares (“Performance Shares”) at the discretion of Global Care at the time a Milestone Target (as defined below) is met for every CDN$14,300,000 in gross revenue generated by High Standard Health Care effective upon High Standard Health Care reaching CDN$21,430,000 in revenue (“Milestone Targets”) up to a maximum of CDN$286,000,000 in gross revenue or 20 Milestone Targets on or before May 31st, 2025 for total value of up to CDN$100,000,000 if all Milestone Targets are achieved.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features